Austal Shares Surge 16% as Hanwha Offers Up to $1.2 Billion for U.S. Shipbuilding Business 
Treasury Wine Estates Shares Jump as U.S. Overhaul Lifts FY2026 Outlook 
AMP Shares Surge 13% After Strong Profit and A$150 Million Buyback 
JPMorgan Plans More Asia-Pacific Hiring in 2027 as Corporate Banking Revenue Surges 
Hanwha Offers Up to $1.2 Billion for Austal US Business 
OpenAI Restricts Astra AI Over Cyberattack Risks 
Hims & Hers Shares Fall as GLP-1 Costs Widen Q2 Loss 
Daimler Truck Q2 Profit Falls 18%, 2026 Outlook Raised 
Trump Media Says Truth API Draws 10+ Customers as Conflict Concerns Grow 
Airbus Joins Air India A320 Altitude Drop Probe 
Sony, TSMC Eye $6.3 Billion Japan Chip Venture for Next-Gen Image Sensors 
Shein Scales Back Vietnam Operations as US Trade Rules Shift 
Deutsche Bank Upgrades Persimmon to Buy After Strong First-Half Results 
Berkshire Hathaway Cash Falls as Abel Boosts Stock Buybacks 
Meta Ordered to Pay $567M Over Child Safety Violations in New Mexico 
Mercedes-Benz Stock Offers Deep-Value Potential as Citi Sees Recovery Catalysts 
Delta Flight Makes Emergency Landing in Atlanta After Cockpit Fumes Reported 
BOWIE, Md., Feb. 16, 2018 -- Inovalon (Nasdaq:INOV), a leading technology company providing advanced, cloud-based platforms empowering a data-driven transformation from volume-based to value-based models across the healthcare ecosystem, today announced that Keith Dunleavy, M.D., chief executive officer and chairman of the board of Inovalon, and Christopher Greiner, chief financial officer and chief operating officer of Inovalon, will present at the Morgan Stanley 2018 Technology, Media & Telecom Conference at The Palace Hotel in San Francisco on Wednesday, February 28, 2018.
Investors may access the presentation on the Investor Relations section of Inovalon’s website at www.inovalon.com. Archived versions will remain posted for a limited time.
About Inovalon
Inovalon is a leading technology company providing cloud-based platforms empowering a data-driven transformation from volume-based to value-based models throughout the healthcare industry. Through the Inovalon ONE™ Platform, Inovalon brings to the marketplace a national-scale capability to interconnect with the healthcare ecosystem, aggregate and analyze data in petabyte volumes to arrive at sophisticated insights in real-time, drive impact wherever it is analytically identified best to intervene, and intuitively visualize data and information to inform business strategy and execution. Leveraging its platform, unparalleled proprietary data sets, and industry-leading subject matter expertise, Inovalon enables the assessment and improvement of clinical and quality outcomes and financial performance across the healthcare ecosystem. From health plans and provider organizations, to pharmaceutical, medical device, and diagnostics companies, Inovalon's unique achievement of value is delivered through the effective progression of “Turning Data into Insight, and Insight into Action®.” Providing technology that supports nearly 500 healthcare organizations, Inovalon's platforms are informed by data pertaining to more than 903,000 physicians, more than 385,000 clinical facilities, and 231 million Americans. For more information, visit www.inovalon.com.
Contacts:
Kim Collins
Phone: 301-809-4000 x1473
[email protected]
George Price (Investors)
Phone: 301-809-4000 x1190
[email protected]
